Many more compounds show efficacy in RCC cells in vitro, through the modulation of key proteins involved in the regulation of apoptosis, such as Akt, Bax, Bcl-2, and Bcl-xL. The gene discussed is BCL2L1; the disease is renal cell adenocarcinoma.